Coherus breached Humira patent settlement by striking deal with Mark Cuban’s drug firm, AbbVie contends kdunleavy Thu, 06/15/2023 – 12:37 More: Coherus breached Humira patent settlement by striking deal with Mark Cuban's drug firm, AbbVie contends Source: fierce
read moreAbbVie’s Skyrizi posts ulcerative colitis win in maintenance study, teeing up FDA nod aliu Thu, 06/15/2023 – 11:02 More: AbbVie's Skyrizi posts ulcerative colitis win in maintenance study, teeing up FDA nod Source: fierce
read moreSandoz reveals plan to boost global biosim uptake, starting in the Americas zbecker Thu, 06/15/2023 – 10:36 More: Sandoz reveals plan to boost global biosim uptake, starting in the Americas Source: fierce
read moreAbbVie sues BeiGene over brand-new Imbruvica patent as blood cancer rivalry heats up aliu Thu, 06/15/2023 – 09:30 More: AbbVie sues BeiGene over brand-new Imbruvica patent as blood cancer rivalry heats up Source: fierce
read moreAbbVie, pursuing post-Humira growth, enlists ex-baseball star to destigmatize bowel disease ntaylor Thu, 06/15/2023 – 09:13 More: AbbVie, pursuing post-Humira growth, enlists ex-baseball star to destigmatize bowel disease Source: fierce
read moreEO2463 is an experimental treatment for indolent non-Hodgkin B cell lymphoma More: Positive profile for Enterome's lymphoma candidate Source: News
read more© 1994 - 2026 B.M. Pharmaceuticals